Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

leukemia, chronic lymphocytic, susceptibility to, 2 - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

leukemia, chronic lymphocytic, susceptibility to, 2

MONDO:0007190

Also known as:leukemia, chronic lymphocytic, susceptibility to, type 2B-cell malignancy, low-gradeClls2

Find Clinical TrialsTrials

Overview

GeneticsAutosomal dominant

Clinical Trials34 registered · 16 recruiting

Clinical Presentation

Features include: Chronic lymphatic leukemia.

Explore clinical features

Diagnosis

Biomarker and diagnostic research for leukemia, chronic lymphocytic, susceptibility to, 2 has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

34 clinical trials registered, 16 recruiting. Interventions under study include drug therapy, other interventions, biologic therapy, and medical devices. Pipeline includes 5 PHASE3, 7 PHASE2, 12 PHASE1. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT05602363](https://clinicaltrials.gov/study/NCT05602363)

Data assembled from 5 of 12 sources · Last updated Oct 3, 2026, 5:10 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

OMIM

Online Mendelian Inheritance in Man

OMIM:109543

Questions for Your Care Team

→Are any of the 34 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Research summaries	71	42%
Laboratory research	49	29%
Disease patterns and progression	22	13%
Testing and diagnosis research	9	5%
New treatment approaches	6	4%
Other research	5	3%
Patient case studies	5	3%
Clinical study results	4	2%

leukemia, chronic lymphocytic, susceptibility to, 2

Overview

Clinical Presentation

Explore clinical features

Diagnosis

Research Landscape

Medical References

External Resources

OMIM

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications